Endothelin receptor antagonist tezosentan attenuates acute lung injury in endotoxemic sheep

被引：0
|
作者：
Kirov, MY
Kuklin, VN
Evgenov, OV
Kirova, SS
Sjöberg, J
Lindahl, SG
Bjertnaes, LJ
机构：
[1] Univ Tromso, Fac Med, Dept Anesthesiol, N-9001 Tromso, Norway
[2] Karolinska Hosp, Dept Anesthesiol, S-10401 Stockholm, Sweden
来源：
INTENSIVE CARE MEDICINE | 2002年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
480
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [21] Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis
    Didier Lebrec
    Jaime Bosch
    Rajiv Jalan
    Francis J. Dudley
    Rada Jessic
    Richard Moreau
    Juan Carlos Garcia-Pagan
    Rajeshwar P. Mookerjee
    Eleonora Chiossi
    Paul L. M. Van Giersbergen
    Andjela Kusic-Pajic
    Jasper Dingemanse
    European Journal of Clinical Pharmacology, 2012, 68 : 533 - 541
  • [22] Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use
    Clozel, M
    Ramuz, H
    Clozel, JP
    Breu, V
    Hess, P
    Löffler, BM
    Coassolo, P
    Roux, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 290 (02): : 840 - 846
  • [23] Cyclosporin increases the exposure to tezosentan, an intravenous dual endothelin receptor antagonist
    van Giersbergen, PLM
    Bodin, F
    Dingemanse, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (04) : 243 - 245
  • [24] Toll-Like Receptor 4 Inhibitor TAK-242 Attenuates Acute Kidney Injury in Endotoxemic Sheep
    Fenhammar, Johan
    Rundgren, Mats
    Forestier, Jakob
    Kalman, Sigridur
    Eriksson, Stefan
    Frithiof, Robert
    ANESTHESIOLOGY, 2011, 114 (05) : 1130 - 1137
  • [25] Tezosentan, a dual endothelin receptor antagonist, decreases mortality and liver injury in rats with cirrhosis following endotoxin administration
    Urbanovicz, W
    Sogni, P
    Tazi, K
    Cazals-Hatem, D
    Barriere, E
    Poirel, O
    Moreau, R
    Lebrec, D
    JOURNAL OF HEPATOLOGY, 2002, 36 : 11 - 12
  • [26] Entry-into-humans study with tezosentan, an intravenous dual endothelin receptor antagonist
    Dingemanse, J
    Clozel, M
    van Giersbergen, PLM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (06) : 795 - 802
  • [27] The in vivo and in vitro disposition profile of the intravenous endothelin receptor antagonist tezosentan in humans
    Treiber, A
    van Giersbergen, PLM
    Dingemanse, J
    DRUG METABOLISM REVIEWS, 2003, 35 : 120 - 120
  • [28] Myocardial Protective Effect of Tezosentan, an Endothelin Receptor Antagonist, for Ischemia-Reperfusion Injury in Experimental Heart Failure Models
    Ryu, Se Min
    Kim, Hark Jei
    Cho, Kyu Ran
    Jo, Won-Min
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (05) : 782 - 788
  • [29] No redistribution of lung blood flow by inhaled nitric oxide in endotoxemic piglets pretreated with an endothelin receptor antagonist
    Trachsel, Sebastien
    Hambraeus-Jonzon, Kristina
    Bergquist, Maria
    Martijn, Cecile
    Chen, Luni
    Hedenstierna, Goran
    JOURNAL OF APPLIED PHYSIOLOGY, 2015, 118 (06) : 768 - 775
  • [30] Tezosentan, a new endothelin receptor antagonist, produces potent pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension
    Fitzgerald, RK
    Ovadia, B
    Reinhartz, O
    Ross, GA
    Johengen, MJ
    Fineman, JR
    CRITICAL CARE MEDICINE, 2001, 29 (12) : A51 - A51
12345